LAKE OSWEGO, Ore., Sept. 8 /PRNewswire-FirstCall/ -- Calypte Biomedical Corporation (OTC Bulletin Board: CBMC - News), medical diagnostic tests manufacturer for the detection of antibodies to the human immunodeficiency virus (HIV) for the professional point of care (PRO) and over the counter (OTC) segments of the market announced today that it has been approved to commence trading on the OTC Bulletin Board ("OTCBB") under the symbol " CBMC " effective with the opening of trading, today, September 8, 2006. To find the Company's information through online financial websites it may be necessary to enter "CBMC.OB".
